3 FTSE 100 income stocks I’ll be avoiding like the plague in 2027

Image source: Getty Images

Since selling Legal & General a couple of months ago, I’ve been searching for a new income stock. While I see a handful of potential candidates, there are some I’m keen to avoid.

Here are three of them from the FTSE 100.

A clear guide to Anthropic’s IPO (without the hype)

A new free report just landed on Anthropic – and we’ve written it for investors who want the facts, not the noise.

We break down what matters most for the IPO question: could it be a genuine potential opportunity… or is it all baseless hype?

There’s no jargon. No hard sell. Just a straightforward read that you can see immediately.

Blockbuster yield

The first dividend stock is Ithaca Energy (LSE:ITH). This UK-focused oil and gas producer sports the highest dividend yield in the index — an eye-popping 9.5% for 2026!

What’s not to like? Well, for starters, I have no idea where energy prices will land next year. But with the Iran war supposedly over, there’s a good chance that oil prices won’t be revisiting this year’s highs.

On the other hand, Ithaca does have oil and gas hedges extending into 2028. So next year’s payout looks safe, as things stand. The firm allocates 30% of its post-tax operating cash flow to dividends.

Plus, there could soon be a regulatory approval of the Rosebank oil field in the UK North Sea, in which Ithaca has a 20% interest. That’s a significant potential growth project.

Then again, there’s no guarantee it will be approved, with up to 100 (mainly Labour) MPs reportedly ready to oppose the development. The energy secretary is minded to reject it, according to The Guardian.

Due to all the uncertainty, this isn’t a stock that interests me, despite the blockbuster yield.

Sluggish sales, low yield

Haleon (LSE:HLN) is another Footsie share I’m steering clear of. This is the consumer healthcare company that owns brands like Sensodyne, Panadol and Beechams.

Now, it could be argued this isn’t much of a dividend stock because it’s only yielding 2.1%. But this is the problem. For a company in a very mature market growing revenue at just 2.5% per year, I would want a significantly higher yield than that.

In Q3, organic revenue growth of 2.6% was below expectations, due to softness in categories like cough, cold and flu consumption. Expected full-year revenue growth of around 2.5% is below the medium-term target of 4%-6%.

Of course, the defensive nature of the stock will appeal to some investors. And there was strong growth in emerging markets in the quarter, led by India with high-teens growth. So there’s certainly nothing fundamentally wrong with the business.

However, due to a combination of low revenue growth and a modest yield, this is another stock that doesn’t interest me.

Healthcare plodder

Finally, GSK (LSE:GSK) is another I’ve long found underwhelming. It has a nasty habit of underperforming the FTSE 100, while offering a so-so dividend yield of 3.7%. That’s not much higher than the index average.

Beyond income, I find it hard to buy into the growth story, with key patents on its HIV franchise beginning to expire before 2029. GSK has set a target of reaching over £40bn in revenue by 2031, up from £32.7bn last year. But investors are yet to be convinced.

The key attraction here is a cheap valuation, with GSK trading at just 9.8 times next year’s forecast earnings. If it can reach its 2031 targets, there could be solid gains to be had here (dividends and share price).

Again though, I find this dividend stock underwhelming. I much prefer this one yielding almost 7%…

What income stock do we like better than GSK right now?

One of our Share Advisor analysts has just released a brand new stock report that we think is a must-read for any investor looking to try and generate potential income.

And the best bit is that you can see if for yourself, right now, absolutely free of charge!

No jargon. No hard sell. Just a clear look at an income share we think is worth your time.

 


Ben McPoland has no position in any of the companies mentioned.

Source link

Visited 1 times, 1 visit(s) today

Related Article

The AI boom had a bad week — and it’s raising loud alarms : NPR

Stocks got hit hard this week amid fears that the AI trade could be buckling. Spencer Platt/Getty Images hide caption toggle caption i Spencer Platt/Getty Images A yearslong AI boom showed signs of unraveling this week in spectacular fashion. AI-related stocks have powered markets to record highs and helped support the broader economy. But investors

Prediction: This International ETF Will Double Your Money in the Next 7 Years

The Vanguard International High Dividend Yield ETF (VYMI) holds 1,502 stocks from financially strong, dividend-paying companies around the world. This fund has delivered strong enough annualized returns to double your money fast. By Ben Gran – Nov 21, 2026 at 5:49AM EST Key Points The Vanguard International High Dividend Yield ETF (VYMI) has outperformed the

President Donald Trump’s Economy and the AI-Driven Stock Market Are in Trouble, Thanks to a Newly Identified Source of Inflation

The stock market has endured some of its most volatile days in history under President Donald Trump. Nevertheless, the iconic Dow Jones Industrial Average (DJINDICES:^DJI), benchmark S&P 500 (SNPINDEX:^GSPC), and tech-fueled Nasdaq Composite (NASDAQINDEX:^IXIC) have averaged higher returns under Trump than under most other presidents since the late 1890s. Some of this outperformance can be

Are crashing BAE Systems shares a dirt cheap buying opportunity?

Image source: Getty Images A recent pullback has dragged BAE Systems‘ (LSE: BA.) shares into crash territory. The share price is now down 20.7% from a high earlier this year. But this is a company that has been thriving. The many billions being pumped into defence budgets have sent the order backlog to record levels,

3 Eurozone Financial Stocks Retail Investors Are Watching After ECB Rate Uncertainty

When the European Central Bank shuffles its top seats while inflation holds at 4% and questions swirl around French debt, bond markets do not sit quietly. Pricing of risk can reset fast, and with it the outlook for large Eurozone financials tied to rates and sovereign yields. This article examines how that shockwave affects three

Where Ranpak Goes After A 52% Drop

If you only skimmed Ranpak’s latest update, modest revenue growth and a smaller quarterly loss might look like progress. For Ranpak shareholders, the loss from the start of the year was 51.7%, including dividends. That gap between improving results and a steep hit to capital raises a blunt question. If you had put money to

Amphastar Pharmaceuticals (AMPH) Stock Looks Reasonable As Earnings Stay Central

Amphastar Pharmaceuticals has seen its share price move around in recent years, and the question now is whether the current valuation can be squared with what the business earns. For anyone following the stock, the key issue is how that earnings profile stacks up against the price on the screen today. Over the past 3

Daily Market Price Updates and Commentary 20th November 2026

  ICE Futures U.S. Sugar No.11 Contract Settlement (cUS$/lb) Open High Low Last Volume O/I Life High Life Low Mar27 17.03 -0.13 ▼ 17.25 17.31 16.82 17.07 108,167 523,251 21.29 14.42 May27 16.37 -0.18 ▼ 16.65 16.70 16.20 16.42 52,783 211,837 20.40 14.29 Jul27 16.04 -0.20 ▼ 16.30 16.38 15.91 16.09 34,617 145,084 19.81 14.27

‘Black Friday’ brings consumer spending into focus for AI-rocked market

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, US, November 18, 2026. REUTERS/Brendan McDermid Brendan McDermid Reuters NEW YORK, Nov 20 (Reuters) – Investors next week will focus on consumer spending, looking for evidence that a broadly solid economy can help calm a US stock market unsettled

Here’s Why Nvidia Stock Crashed on Friday

Reports of a new investigation drove many investors to sell. By Joe Tenebruso – Nov 20, 2026 at 8:25PM EST Shares of Nvidia (NVDA -14.01%) plunged 14% on Friday following reports that the U.S. Securities and Exchange Commission (SEC) is investigating the tech titan’s accounting practices. Image source: Getty Images. Regulatory probes It’s a challenging

Gold falls toward $3,500, silver slides as stock markets enter correction territory – Kitco PM Report

(Kitco NewsWire) – Spot gold and silver prices were sharply lower in late U.S. trading Friday, extending their recent selloff as a historic technology-led equity market decline and expectations for additional Federal Reserve interest rate increases pressured precious metals. Gold approached the psychologically important $3,500 level, trading at its lowest prices since September 2025, while silver suffered

Micron Is Down 32% in a Month. Can MU Stock Get Back to $1,000?

Quick Read Micron (MU) plunged 32% in a month to $605 as doubts grow over how long the AI memory boom can last. UBS warns against companies whose valuations depend on persistent bottlenecks, while Western Digital and Seagate sank similar amounts despite strong revenue growth. Reclaiming $1,000 requires firm memory pricing and strong guidance, with

7 reasons why tech stocks are getting hammered again

So much for the much-hyped Anthropic (ANT) IPO on Thursday lifting the spirits of tech investors ahead of the holidays. Lost in all the Anthropic IPO coverage yesterday was the fact that, while the stock finished up nicely on its debut day, the tech-heavy Nasdaq Composite (^IXIC) fell 2.2%. The selling pressure in wider tech

6 reasons stocks are falling, and what you should do about it

The stock market is having its roughest patch since the early days of the pandemic.  Stocks wavered on Friday after tumbling the previous day, with the S&P 500 on track to mark its seventh consecutive day of losses. That would mark its longest losing streak since February 2020, when investors fled the market amid the

0
Would love your thoughts, please comment.x
()
x